Page 109 - Vitamin D and Cancer

96 E. Giovannucci

70. Gissel T, Rejnmark L, Mosekilde L, Vestergaard P (2008) Intake of vitamin D and risk of
breast cancer: a meta-analysis. J Steroid Biochem Mol Biol 111:195–199
71. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy
products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst
94:1301–1310
72. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R (2007) Vitamin D and reduced risk of
breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev
16:422–429
73. John EM, Schwartz GG, Koo J, Wang W, Ingles SA (2007) Sun exposure, vitamin D receptor
gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol
166:1409–1419
74. John EM, Schwartz GG, Dreon DM, Koo J (1999) Vitamin D and breast cancer risk: the
NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. National Health and
Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 8:399–406
75. Stolzenberg-Solomon RZ, Vieth R, Azad A et al (2006) A prospective nested case–control
study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res
66:10213–10219
76. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted vitamin
D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer
102:1422–1427
77. Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2006) Vitamin
D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol
Biomarkers Prev 15:1688–1695
78. Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE (2007) Plasma
25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D and risk of incident ovarian cancer.
Cancer Epidemiol Biomarkers Prev 16:783–788
79. Chen W, Dawsey SM, Qiao YL et al (2007) Prospective study of serum 25(OH)-vitamin D
concentration and risk of oesophageal and gastric cancers. Br J Cancer 97:123–128
80. Abnet CC, Chen W, Dawsey SM et al (2007) Serum 25(OH)-vitamin D concentration and risk
of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 16:1889–1893
81. Kricker A, Armstrong BK, Hughes AM et al (2008) Personal sun exposure and risk of non
Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer
122:144–154
82. Freedman DM, Zahm SH, Dosemeci M (1997) Residential and occupational exposure to
sunlight and mortality from non-Hodgkin’s lymphoma: composite (threefold) case-control
study. BMJ 314:1451–1455
83. Norval M, McLoone P, Lesiak A, Narbutt J (2008) The effect of chronic ultraviolet radiation
on the human immune system. Photochem Photobiol 84:19–28
84. Pilz S, Dobnig H, Winklhofer-Roob B et al (2008) Low serum levels of 25-hydroxyvitamin D
predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol
Biomarkers Prev 17:1228–1233
85. Ducloux D, Courivaud C, Bamoulid J, Kazory A, Dumoulin G, Chalopin JM (2008)
Pretransplant serum vitamin D levels and risk of cancer after renal transplantation.
Transplantation 85:1755–1759
86. Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol)
supplementation on fractures and mortality in men and women living in the community: ran-
domized double blind controlled trial. BMJ 326:469–475
87. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007) Vitamin D and
calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr
85:1586–1591
88. Schwartz GG, Hanchette CL (2006) UV, latitude, and spatial trends in prostate cancer mortal-
ity: all sunlight is not the same (United States). Cancer Causes Control 17:1091–1101